Budapest, Hungary

Endre Kollár


Average Co-Inventor Count = 17.5

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Inventor Endre Kollár: Innovating Pharmaceutical Processes in Budapest**

Introduction

Endre Kollár, an inventive mind based in Budapest, Hungary, has made significant strides in the field of chemistry, particularly in pharmaceutical processes. With two patents to his name, Kollár's contributions are geared towards enhancing the synthesis of vital compounds. His work is instrumental in the development of intermediates valuable for medical applications.

Latest Patents

Kollár's latest patents focus on the preparation of 1,3-diaza-spiro (4.4) non-1-en-4-one derivatives and 1-cyano-1-acylamino-cyclopentane intermediates. The patented processes involve sophisticated chemical reactions that transform compound structures, ensuring that the results are useful in synthesizing angiotensin II antagonists. Specifically, the processes outline reactions involving varied compounds, incorporating oxidizing agents to achieve desired chemical transformations characterized by specific formulae.

Career Highlights

Kollár currently works with Sanofi Synthelabo, where his expertise in pharmaceutical innovation thrives. His career is marked by a commitment to advancing chemical synthesis methodologies, a critical element in the pharmaceutical industry. His patents not only underscore his inventiveness but also reflect the ongoing need for innovative solutions in drug development.

Collaborations

Throughout his career, Kollár has collaborated with notable co-workers, including Attila Kis-Tamás and Csaba Huszár. These collaborations have played a vital role in advancing their collective work, leading to significant breakthroughs in the synthesis of chemical compounds and furthering pharmaceutical research.

Conclusion

Endre Kollár stands out as a prominent inventor whose work is contributing to the advancement of pharmaceutical sciences. His innovative processes are paving the way for the development of essential therapeutic agents, showcasing the impact that dedicated inventors have on society and health care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…